SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

57/100

4/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para SpringWorks Therapeutics, Inc. (SWTX), incluyendo 15 compras y 35 ventas. El total de compras internas fue valorado en $18.8M y el total de ventas internas en $16.02M.

Internos destacados con actividad reciente incluyen Lynch Daniel, Fuhrman Alan, Mackay Martin. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — SWTX

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2025-05-14	Lynch Daniel	Director	Concesión de RSU	10,060	-	-	93,004
2025-05-14	Fuhrman Alan	Director	Concesión de RSU	10,060	-	-	24,727
2025-05-14	Mackay Martin	Director	Concesión de RSU	10,060	-	-	20,023
2025-05-14	Lewis-hall Freda C	Director	Concesión de RSU	10,060	-	-	24,727
2025-05-14	Alban Carlos	Director	Concesión de RSU	10,060	-	-	28,861
2025-05-14	Hambleton Julie	Director	Concesión de RSU	10,060	-	-	14,155
2025-03-03	Islam Saqib	Chief Executive Officer	Venta Informativa	600	$56.89	$34.13K	954,869
2025-03-03	Edris Badreddin	Chief Operating Officer	Venta Informativa	400	$56.20	$22.48K	169,712
2025-02-27	Islam Saqib	Chief Executive Officer	Retención Fiscal de RSU	30,756	$53.41	$1.64M	1,003,869
2025-02-20	Lynch Daniel	Director	Venta Informativa	3,582	$61.24	$219.35K	82,944
2025-02-20	Islam Saqib	Chief Executive Officer	Venta Informativa	5,068	$61.24	$310.35K	1,034,625
2025-02-20	Ashar Bhavesh	Chief Commercial Officer	Venta Informativa	1,016	$61.19	$62.17K	62,053
2025-02-14	Lynch Daniel	Director	Venta Informativa	400	$60.00	$24K	130,544
2025-02-14	Islam Saqib	Chief Executive Officer	Venta Informativa	10,672	$59.92	$639.49K	1,063,953
2025-02-12	Islam Saqib	Chief Executive Officer	Retención Fiscal de RSU	13,186	$59.28	$781.67K	1,074,625
2025-02-10	Lynch Daniel	Director	Venta Informativa	65,600	$55.51	$3.64M	130,944
2025-02-10	Islam Saqib	Chief Executive Officer	Venta Informativa	48,000	$53.30	$2.56M	1,002,502
2025-02-10	Hambleton Julie	Director	Ejercicio de Opciones (Venta)	13,774	$32.27	$444.49K	-
2025-02-10	Edris Badreddin	Chief Operating Officer	Venta Informativa	30,000	$53.13	$1.59M	189,712
2025-02-10	Pichl Daniel	Chief People Officer	Ejercicio de Opciones (Venta)	13,750	$27.64	$380.05K	31,250
2025-01-10	Perier Francis I Jr	Chief Financial Officer	Concesión de RSU	34,419	$43.00	$1.48M	34,419
2025-01-10	Weinstein Herschel S	General Counsel & Secretary	Concesión de RSU	35,431	$43.00	$1.52M	35,431
2025-01-10	Islam Saqib	Chief Executive Officer	Concesión de RSU	109,329	$43.00	$4.7M	109,329
2025-01-10	Nofi Michael	Chief Accounting Officer	Concesión de RSU	20,246	$43.00	$870.58K	20,246
2025-01-10	Edris Badreddin	Chief Operating Officer	Concesión de RSU	78,960	$43.00	$3.4M	78,960
2025-01-10	Pichl Daniel	Chief People Officer	Concesión de RSU	37,455	$43.00	$1.61M	37,455
2025-01-10	Ashar Bhavesh	Chief Commercial Officer	Concesión de RSU	50,615	$43.00	$2.18M	50,615
2025-01-10	Cassidy James	Chief Medical Officer	Concesión de RSU	50,615	$43.00	$2.18M	50,615
2025-01-10	Lin Tai-an	Chief Scientific Officer	Concesión de RSU	20,246	$43.00	$870.58K	20,246
2025-01-06	Perier Francis I Jr	Chief Financial Officer	Retención Fiscal de RSU	3,283	$38.86	$127.58K	49,110
2025-01-06	Weinstein Herschel S	General Counsel & Secretary	Retención Fiscal de RSU	2,279	$38.86	$88.56K	43,113
2025-01-06	Islam Saqib	Chief Executive Officer	Retención Fiscal de RSU	12,359	$38.86	$480.27K	975,668
2025-01-06	Nofi Michael	Chief Accounting Officer	Retención Fiscal de RSU	1,009	$38.86	$39.21K	23,694
2025-01-06	Edris Badreddin	Chief Operating Officer	Retención Fiscal de RSU	4,416	$38.86	$171.61K	192,689
2025-01-06	Pichl Daniel	Chief People Officer	Retención Fiscal de RSU	1,759	$38.86	$68.35K	37,943
2025-01-06	Ashar Bhavesh	Chief Commercial Officer	Retención Fiscal de RSU	2,284	$38.86	$88.76K	45,746
2025-01-06	Cassidy James	Chief Medical Officer	Retención Fiscal de RSU	1,658	$38.86	$64.43K	64,408
2025-01-05	Perier Francis I Jr	Chief Financial Officer	Retención Fiscal de RSU	3,278	$38.19	$125.19K	52,393
2025-01-05	Weinstein Herschel S	General Counsel & Secretary	Retención Fiscal de RSU	3,272	$38.19	$124.96K	45,392
2025-01-05	Islam Saqib	Chief Executive Officer	Retención Fiscal de RSU	12,872	$38.19	$491.58K	988,027
2025-01-05	Nofi Michael	Chief Accounting Officer	Retención Fiscal de RSU	1,636	$38.19	$62.48K	24,703
2025-01-05	Edris Badreddin	Chief Operating Officer	Retención Fiscal de RSU	5,561	$38.19	$212.37K	197,105
2025-01-05	Pichl Daniel	Chief People Officer	Retención Fiscal de RSU	2,522	$38.19	$96.32K	39,702
2025-01-05	Ashar Bhavesh	Chief Commercial Officer	Retención Fiscal de RSU	3,825	$38.19	$146.08K	48,030
2025-01-05	Cassidy James	Chief Medical Officer	Retención Fiscal de RSU	3,465	$38.19	$132.33K	66,066
2025-01-04	Perier Francis I Jr	Chief Financial Officer	Retención Fiscal de RSU	3,582	$38.19	$136.8K	55,671
2025-01-04	Weinstein Herschel S	General Counsel & Secretary	Retención Fiscal de RSU	3,575	$38.19	$136.53K	48,664
2025-01-04	Islam Saqib	Chief Executive Officer	Retención Fiscal de RSU	13,469	$38.19	$514.38K	1,000,899
2025-01-04	Nofi Michael	Chief Accounting Officer	Retención Fiscal de RSU	2,388	$38.19	$91.2K	26,339
2025-01-04	Edris Badreddin	Chief Operating Officer	Retención Fiscal de RSU	6,934	$38.19	$264.81K	202,666

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento